Biofficient Successfully Launches "Match.com" for Biotech Industry at DIA 2013
Boston-Based Startup Debuts First-of-its-Kind Platform Automating RFP Process for Clinical Trial Sponsors and Service Providers
Boston-Based Startup Debuts First-of-its-Kind Platform Automating RFP Process for Clinical Trial Sponsors and Service Providers
Biofficient Inc. today announced the successful launch of its new platform to accelerate the outsourcing process for the biopharmaceutical drug development process. The company debuted the product to the biotech industry at last week’s annual DIA conference in Boston, MA.
Biofficient.com, the company’s website which hosts the platform, offers a streamlined solution to the arduous process of matching clinical trial sponsors’ specific needs with a comprehensive database of contract services provided by a global list of industry vendors. Completely secure and confidential, sponsors are able to create and send their RFPs to the vendors they select from a list generated by Biofficient’s adaptive matching algorithms.
On the other side of the process, Biofficient opens doors to new business for thousands of vendors that may otherwise not have been aware of valuable projects within their realm of expertise. By building out their free vendor profile on Biofficient’s easy-to-navigate site, qualified companies become a visible, viable contender for business in a highly competitive marketplace.
“We saw an opportunity to greatly improve the inefficiencies on both sides of the biopharmaceutical RFP process, and built out a solution that is beneficial to both the trial sponsors and contract service vendors. In a market that is increasingly relying on outsourced work, a faster, simpler, more cost-efficient way of bringing both parties together and improving the quality of the entire experience as a whole is critical,” said Biofficient CEO Bret Siarkowski..
For more information about Biofficient, or to register for their platform, visit www.biofficient.com or call (888) 560-7007.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
